首页|双歧杆菌四联活菌片辅助序贯疗法治疗HP相关性慢性萎缩性胃炎的效果观察

双歧杆菌四联活菌片辅助序贯疗法治疗HP相关性慢性萎缩性胃炎的效果观察

扫码查看
目的:探究双歧杆菌四联活菌片辅助治疗幽门螺杆菌(Hp)相关性慢性萎缩性胃炎的临床疗效.方法:选取周口市中医院2021年1月—2023年1月收治的Hp相关性慢性萎缩性胃炎患者97例,按随机数字表法分为治疗组(n=49)和对照组(n=48).对照组采取序贯疗法治疗,观察组给予序贯疗法联合双歧杆菌四联活菌片治疗.比较两组临床疗效、Hp根除率、不良反应发生情况及炎症因子[白细胞介素-6(IL-6)、C反应蛋白(CRP)、血清肿瘤坏死因子-α(TNF-α)]、胃蛋白酶原[胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)、PGⅠ/PGⅡ]水平变化.结果:治疗组总有效率为95.83%,高于对照组的74.47%,差异有统计学意义(P<0.05);治疗组根除率为95.83%,高于对照组的74.47%,差异有统计学意义(P<0.05).治疗后,治疗组IL-6、CRP、TNF-α水平低于对照组,PGⅠ、PGⅠ/PGⅡ水平高于对照组,差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:双歧杆菌四联活菌片辅助治疗Hp相关性慢性萎缩性胃炎的临床效果良好,能有效抑制机体炎性因子水平,提高胃蛋白酶原水平,促进胃黏膜修复,且安全性较高.
Observation on the Effect of Combined Live Bifidobacterium,Lactobacillus,Enterococcus and Bacillus Cereus Tablets Assisted Sequential Therapy in the Treatment of HP Related Chronic Atrophic Gastritis
Objective:To explore the clinical efficacy of Combined Live Bifidobacterium,Lactobacillus,Enterococcus and Bacillus Cereus Tablets in the adjuvant treatment of Helicobacter pylori(Hp)-related chronic atrophic gastritis.Methods:A total of 97 patients with Hp-related chronic atrophic gastritis admitted to our hospital from January 2021 to January 2023 were selected and divided into treatment group(n=49)and control group(n=48)according to the random number table method.The control group was treated with sequential therapy,and the observation group was treated with sequential therapy combined with Combined Live Bifidobacterium,Lactobacillus,Enterococcus and Bacillus Cereus Tablets.The clinical efficacy,Hp eradication rate,adverse reactions and inflammatory factors[interleukin-6(IL-6),C-reactive protein(CRP),serum tumor necrosis factor-α(TNF-α)],pepsinogen[pepsinogen Ⅰ(PGⅠ),pepsinogen Ⅱ(PGⅡ),PGⅠ/PGⅡ]were compared between the two groups.Results:The total effective rate of the treatment group was 95.83%,which was higher than 74.47%of the control group,and the difference was statistically significant(P<0.05).The eradication rate of the treatment group was 95.83%,which was higher than 74.47%of the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of IL-6,CRP and TNF-α in the treatment group were lower than those in the control group,and the levels of PGI and PGⅠ/PGⅡ were higher than those in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Combined Live Bifidobacterium,Lactobacillus,Enterococcus and Bacillus Cereus Tablets have a good clinical effect in the adjuvant treatment of Hp-related chronic atrophic gastritis,which can effectively inhibit the level of inflammatory factors,improve the level of pepsinogen,promote the repair of gastric mucosa,and have high safety.

Combined Live Bifidobacterium,Lactobacillus,Enterococcus and Bacillus Cereus TabletsHP-associated chronic atrophic gastritisHP eradication ratePepsinogen

程中杰、孙科、郭蔚

展开 >

周口市中医院中西结合科,河南 周口 466000

周口市中心医院肾病风湿免疫科,河南 周口 466000

双歧杆菌四联活菌片 HP相关性慢性萎缩性胃炎 Hp根除率 胃蛋白酶原

国家卫生健康委"十四五"规划课题

YYWS4805

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(7)